RISK OF HEPATOCARCINOGENESIS AFTER ERADICATION OF HEPATITIS C VIRUS BY DIRECT ACTING ANTIVIRALS

被引：0
|
作者：
Kawaguchi, Yasunori
Otsuka, Taiga
Yoshioka, Wataru
Noge, Shotaro
Takahashi, Hirokazu
Eguchi, Yuichiro
Ozaki, Iwata
Okada, Michiaki
Yanagita, Kimihiko
Kohira, Toshikazu
Ide, Yasushi
Yasutake, Tsutomu
Kawasoe, Hiroaki
Mizuta, Toshihiko
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33701-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1530
引用
收藏
页码：S1099 / S1099
页数：1
相关论文
共 50 条
  • [1] Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
    Lee, Hye Won
    Han, Dai Hoon
    Shin, Hye Jung
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    CANCERS, 2020, 12 (11) : 1 - 13
  • [2] LONG- TERM PROGNOSIS AFTER DIRECT ACTING ANTIVIRALS TREATMENT WITH HEPATITIS C VIRUS ERADICATION
    Kurosaki, Masayuki
    Tamaki, Nobuharu
    Izumi, Namiki
    HEPATOLOGY, 2023, 78 : S697 - S697
  • [3] Impact of hepatitis C virus eradication with direct-acting antivirals on glycidic metabolism
    Sparvoli, Juceli Marcia Hendges
    Sparvoli, Antonio Cardoso
    Dumith, Samuel de Carvalho
    Pereira, Afonso Alexandre
    de Paula, Ana Luisa Machado
    Garcia, Lais
    Belarmino, Vanusa
    da Hora, Vanusa Pousada
    de Martinez, Ana Maria Barral
    Goncalves, Carla Vitola
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67 (03): : 314 - 322
  • [4] Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals
    Akuta, Norio
    Kobayashi, Masahiro
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    ONCOLOGY, 2016, 91 (06) : 341 - 347
  • [5] Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication
    Przybyszewski, Eric M.
    Chung, Raymond T.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 : S226 - S231
  • [6] Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals
    Nagaoki, Yuko
    Yamaoka, Kenji
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Fujino, Hatsue
    Ono, Atsushi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Aikata, Hiroshi
    Hayes, C. Nelson
    Tsuge, Masataka
    Oka, Shiro
    LIVERS, 2024, 4 (03): : 352 - 363
  • [7] Risk of hepatocellular carcinoma for patients treated with direct-acting antivirals: steps after hepatitis C virus eradication to achieve elimination
    Lee, Mei-Hsuan
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
  • [8] The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
    Chinchilla-Lopez, Paulina
    Qi, Xingshun
    Yoshida, Eric M.
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 328 - 330
  • [9] Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals
    Cuciureanu, Tudor
    Stanciu, Carol
    Nastasa, Robert Radu
    Stratina, Larisa Ermina
    Minea, Horia Octav
    Zenovia, Ioan Sebastian
    Sfarti, Catalin
    Muzica, Cristina Maria
    Huiban, Laura
    Stafie, Remus Theodor
    Singeap, Ana-Maria
    Chiriac, Stefan
    Cojocariu, Eliza Camelia
    Girleanu, Irina
    Petrea, Oana Cristina
    Timofeiov, Sergiu
    Cuciureanu, Iulian Dan
    Rotaru, Adrian
    Trifan, Anca
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2023, 64 (04): : 483 - 491
  • [10] Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals
    Lucia Cerrito
    Maria Elena Ainora
    Alberto Nicoletti
    Matteo Garcovich
    Laura Riccardi
    Maurizio Pompili
    Antonio Gasbarrini
    Maria Assunta Zocco
    World Journal of Hepatology, 2021, (11) : 1663 - 1676
12345